In 2004, the group cooperated with Mr. Tu Youyou to jointly develop artemisinin-based anti-malaria drugs (ACT), and invested in the establishment of Anhui Xinhecheng Wannan Pharmaceutical Company, which covers an area of 250,000 square meters. After the antimalarial drug was put into production, its market share in Africa reached 40% in less than two years, which greatly improved the situation that there were no effective drugs in the global antimalarial industry.

Because of the excellent performance of antimalarial drugs in the market, Pfizer, the world's largest pharmaceutical group in the United States, sought to cooperate with the group to jointly develop artemisinin-based antimalarial drugs, and successfully signed a cooperation agreement in 2006. This move created the history of Pfizer's OEM in non-system factories. The group and Chairman Lin Zhongxuan became the global partner of Pfizer's anti-malaria business.

Because of the Group's success in the African market, when the President of China Hu Jintao visited Africa in 2006, the Chairman was one of the entrepreneurs who were met by the president and interviewed on a small scale. The Chairman was also received by the presidents and Prime ministers of Ghana, Algeria, Nigeria and other six countries.

Thanks to the widespread use of new antimalarial drugs, the number of malaria deaths worldwide dropped from 3 million in 2005 to less than 1 million in 2015, saving tens of millions of lives in a decade. Dr. Tu Youyou also won the Nobel Prize for her great invention of artemisinin, and the Group has made a strong contribution to the global anti-malaria cause.